NCT02332590methotrexatesarilumabadalimumabrheumatoid arthritisRAMONARCH trial
….Methods This study used blood samples from the MONARCH trial ( NCT02332590), a randomised, double-blind, phase III trial that compared the…
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT02332590 ×
NCT02332590
This funder is selected. Its supporting articles are shown below.